233 related articles for article (PubMed ID: 20187637)
1. Characteristics and antioxidant activity of Elsholtzia splendens extract-loaded nanoparticles.
Lee JS; Kim GH; Lee HG
J Agric Food Chem; 2010 Mar; 58(6):3316-21. PubMed ID: 20187637
[TBL] [Abstract][Full Text] [Related]
2. Antioxidant idebenone-loaded nanoparticles based on chitosan and N-carboxymethylchitosan.
Amorim Cde M; Couto AG; Netz DJ; de Freitas RA; Bresolin TM
Nanomedicine; 2010 Dec; 6(6):745-52. PubMed ID: 20599528
[TBL] [Abstract][Full Text] [Related]
3. Preparation of drug-loaded polymeric nanoparticles and evaluation of the antioxidant activity against lipid peroxidation.
Pohlmann AR; Schaffazick SR; Creczynski-Pasa TB; Guterres SS
Methods Mol Biol; 2010; 610():109-21. PubMed ID: 20013175
[TBL] [Abstract][Full Text] [Related]
4. Preparation, characterization and in vitro release study of carvacrol-loaded chitosan nanoparticles.
Keawchaoon L; Yoksan R
Colloids Surf B Biointerfaces; 2011 May; 84(1):163-71. PubMed ID: 21296562
[TBL] [Abstract][Full Text] [Related]
5. Preparation of N,O-carboxymethyl chitosan nanoparticles as an insulin carrier.
Lin CC; Lin CW
Drug Deliv; 2009 Nov; 16(8):458-64. PubMed ID: 19839790
[TBL] [Abstract][Full Text] [Related]
6. Heparin/chitosan nanoparticle carriers prepared by polyelectrolyte complexation.
Liu Z; Jiao Y; Liu F; Zhang Z
J Biomed Mater Res A; 2007 Dec; 83(3):806-12. PubMed ID: 17559117
[TBL] [Abstract][Full Text] [Related]
7. Chitosan-hyaluronic acid nanoparticles loaded with heparin for the treatment of asthma.
Oyarzun-Ampuero FA; Brea J; Loza MI; Torres D; Alonso MJ
Int J Pharm; 2009 Nov; 381(2):122-9. PubMed ID: 19467809
[TBL] [Abstract][Full Text] [Related]
8. [Free amino groups on the surface of chitosan nanoparticles and its characteristics].
Lin AH; Liu YM; Ping QN
Yao Xue Xue Bao; 2007 Mar; 42(3):323-8. PubMed ID: 17520835
[TBL] [Abstract][Full Text] [Related]
9. Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting.
Wang X; Chi N; Tang X
Eur J Pharm Biopharm; 2008 Nov; 70(3):735-40. PubMed ID: 18684400
[TBL] [Abstract][Full Text] [Related]
10. Evaluation and modification of N-trimethyl chitosan chloride nanoparticles as protein carriers.
Chen F; Zhang ZR; Huang Y
Int J Pharm; 2007 May; 336(1):166-73. PubMed ID: 17145144
[TBL] [Abstract][Full Text] [Related]
11. Polyelectrolyte nanoparticles based on water-soluble chitosan-poly(L-aspartic acid)-polyethylene glycol for controlled protein release.
Shu S; Zhang X; Teng D; Wang Z; Li C
Carbohydr Res; 2009 Jul; 344(10):1197-204. PubMed ID: 19508912
[TBL] [Abstract][Full Text] [Related]
12. Ascorbyl palmitate-loaded chitosan nanoparticles: characteristic and polyphenol oxidase inhibitory activity.
Kim MK; Lee JS; Kim KY; Lee HG
Colloids Surf B Biointerfaces; 2013 Mar; 103():391-4. PubMed ID: 23247266
[TBL] [Abstract][Full Text] [Related]
13. Self-aggregated nanoparticles from linoleic acid modified carboxymethyl chitosan: Synthesis, characterization and application in vitro.
Tan YL; Liu CG
Colloids Surf B Biointerfaces; 2009 Mar; 69(2):178-82. PubMed ID: 19124228
[TBL] [Abstract][Full Text] [Related]
14. The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing.
Liu X; Howard KA; Dong M; Andersen MØ; Rahbek UL; Johnsen MG; Hansen OC; Besenbacher F; Kjems J
Biomaterials; 2007 Feb; 28(6):1280-8. PubMed ID: 17126901
[TBL] [Abstract][Full Text] [Related]
15. Chitosan nanoparticles as a novel delivery system for ammonium glycyrrhizinate.
Wu Y; Yang W; Wang C; Hu J; Fu S
Int J Pharm; 2005 May; 295(1-2):235-45. PubMed ID: 15848008
[TBL] [Abstract][Full Text] [Related]
16. Intravesical cationic nanoparticles of chitosan and polycaprolactone for the delivery of Mitomycin C to bladder tumors.
Bilensoy E; Sarisozen C; Esendağli G; Doğan AL; Aktaş Y; Sen M; Mungan NA
Int J Pharm; 2009 Apr; 371(1-2):170-6. PubMed ID: 19135514
[TBL] [Abstract][Full Text] [Related]
17. Safety evaluation of Elsholtzia splendens extracts: assessment of acute toxicity and mutagenicity.
Shim SM; Choi MH; Kim GH
Food Chem Toxicol; 2008 Mar; 46(3):1042-7. PubMed ID: 18068883
[TBL] [Abstract][Full Text] [Related]
18. Preparation and evaluation of N-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting.
Lin A; Chen J; Liu Y; Deng S; Wu Z; Huang Y; Ping Q
Drug Dev Ind Pharm; 2009 Nov; 35(11):1348-55. PubMed ID: 19832635
[TBL] [Abstract][Full Text] [Related]
19. Design and characterization of antitumor drug paclitaxel-loaded chitosan nanoparticles by W/O emulsions.
Xu J; Ma L; Liu Y; Xu F; Nie J; Ma G
Int J Biol Macromol; 2012 Mar; 50(2):438-43. PubMed ID: 22230611
[TBL] [Abstract][Full Text] [Related]
20. Self-assembled nanoparticles based on hydrophobically modified chitosan as carriers for doxorubicin.
Zhang J; Chen XG; Li YY; Liu CS
Nanomedicine; 2007 Dec; 3(4):258-65. PubMed ID: 17962086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
